Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management
- PMID: 11056411
Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management
Abstract
Attention Deficit/Hyperactivity Disorder (ADHD) is the most common behavioral disorder in children. ADHD is characterized by attention deficit, impulsivity, and sometimes overactivity ("hyperactivity"). The diagnosis is empirical, with no objective confirmation available to date from laboratory measures. ADHD begins in childhood and often persists into adulthood. The exact etiology is unknown; genetics plays a role, but major etiologic contributors also include adverse responses to food additives, intolerances to foods, sensitivities to environmental chemicals, molds, and fungi, and exposures to neurodevelopmental toxins such as heavy metals and organohalide pollutants. Thyroid hypofunction may be a common denominator linking toxic insults with ADHD symptomatologies. Abnormalities in the frontostriatal brain circuitry and possible hypofunctioning of dopaminergic pathways are apparent in ADHD, and are consistent with the benefits obtained in some instances by the use of methylphenidate (Ritalin) and other potent psychostimulants. Mounting controversy over the widespread use of methylphenidate and possible life-threatening effects from its long-term use make it imperative that alternative modalities be implemented for ADHD management. Nutrient deficiencies are common in ADHD; supplementation with minerals, the B vitamins (added in singly), omega-3 and omega-6 essential fatty acids, flavonoids, and the essential phospholipid phosphatidylserine (PS) can ameliorate ADHD symptoms. When individually managed with supplementation, dietary modification, detoxification, correction of intestinal dysbiosis, and other features of a wholistic/integrative program of management, the ADHD subject can lead a normal and productive life.
Comment in
-
ADHD, Ritalin, and big brother.Altern Med Rev. 2000 Oct;5(5):401. Altern Med Rev. 2000. PMID: 11056410 No abstract available.
Similar articles
-
[The role of zinc in the treatment of hyperactivity disorder in children].Acta Med Croatica. 2009 Oct;63(4):307-13. Acta Med Croatica. 2009. PMID: 20034331 Review. Croatian.
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Attention-deficit hyperactivity disorder.Clin Pharm. 1990 Aug;9(8):632-42. Clin Pharm. 1990. PMID: 1974836 Review.
-
Attention-deficit-hyperactivity disorder: an update.Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Pharmacotherapy. 2009. PMID: 19476419 Review.
-
[Prescribing ritalin in combined modality management of hyperactivity with attention deficit].Encephale. 2001 Sep-Oct;27(5):435-43. Encephale. 2001. PMID: 11760693 French.
Cited by
-
Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.Nutr J. 2008 Feb 14;7:8. doi: 10.1186/1475-2891-7-8. Nutr J. 2008. PMID: 18275609 Free PMC article.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2023 Mar 27;3:CD009885. doi: 10.1002/14651858.CD009885.pub3. PMID: 26599576 Free PMC article. Updated.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971690 Free PMC article.
-
Phosphatidylserine Counteracts the High Stocking Density-Induced Stress Response, Redox Imbalance and Immunosuppression in Fish Megalobrama ambylsephala.Antioxidants (Basel). 2024 May 25;13(6):644. doi: 10.3390/antiox13060644. Antioxidants (Basel). 2024. PMID: 38929083 Free PMC article.
-
Are children with attention-deficit/ hyperactivity disorder (ADHD) more likely to develop celiac disease? A prospective study.Postep Psychiatr Neurol. 2023 Jun;32(2):92-95. doi: 10.5114/ppn.2023.127573. Epub 2023 Jun 2. Postep Psychiatr Neurol. 2023. PMID: 37497198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical